ABT Abbott Laboratories
Healthcare
Price
$109.93
Intrinsic value
$21.10
Buy price
$16.88
Discount
-420.9%
DCF walkthrough
Near-term growth (g1)0.00%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $9,464,000,000.00
- Total debt
- $32,719,998,976.00
- Cash & STI
- $5,602,999,808.00
- Shares out.
- 1,742,981,000
Overvalued
Intrinsic value$21.11
Buy price (with MOS)$16.89
Current price$109.93
Discount to intrinsic value-420.8%
7-step quality scorecard
ROE quality
HIGH_CONSISTENT- Average ROE
- 18.6%
- Current ROE
- 12.5%
- Minimum ROE
- 12.5%
Debt quality
MODERATE- Debt / Equity
- 0.63x
Moat proxy
STRONG_PROXYCash-flow reliability
OK- Operating CF / Net income
- 1.75x
Technical chart
Confluence: DOWNTREND (2/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- min(cfCAGR,revenueCAGR)
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 50.8%
- Public economic interest
- 98.8%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.